{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:15:25Z","timestamp":1776824125118,"version":"3.51.2"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Economic Development, Sustainability and Environment of the Basque Government","award":["Elkartek-KK-2022\/00038"],"award-info":[{"award-number":["Elkartek-KK-2022\/00038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01667-6","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T11:49:11Z","timestamp":1745495351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Platelet-rich plasma activation: are there differential effects in reproductive medicine?"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8386-5303","authenticated-orcid":false,"given":"Eduardo","family":"Anitua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-1517","authenticated-orcid":false,"given":"Mar\u00eda","family":"de la Fuente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4767-7206","authenticated-orcid":false,"given":"Roberto","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4422-4527","authenticated-orcid":false,"given":"Mohammad H.","family":"Alkhraisat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"3","key":"1667_CR1","first-page":"303","volume":"10","author":"E Anitua","year":"2023","unstructured":"Anitua E, Allende M, de la Fuente M, Del Fabbro M, Alkhraisat MH. Efficacy of Platelet-Rich plasma in women with a history of embryo transfer failure: A systematic review and Meta-Analysis with trial sequential analysis. Bioeng (Basel Switzerland). 2023;10(3):303.","journal-title":"Bioeng (Basel Switzerland)"},{"issue":"7","key":"1667_CR2","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/humrep\/deab106","volume":"36","author":"L Atkinson","year":"2021","unstructured":"Atkinson L, Martin F, Sturmey RG. Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon? Hum Reprod. 2021;36(7):1737\u201350.","journal-title":"Hum Reprod"},{"issue":"24","key":"1667_CR3","doi-asserted-by":"publisher","first-page":"17336","DOI":"10.3390\/ijms242417336","volume":"24","author":"B Nagy","year":"2023","unstructured":"Nagy B, Kovacs K, Sulyok E, Varnagy A, Bodis J. Thrombocytes and Platelet-Rich plasma as modulators of reproduction and fertility. Int J Mol Sci. 2023;24(24):17336.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1667_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.tjog.2018.10.007","volume":"57","author":"M Eftekhar","year":"2018","unstructured":"Eftekhar M, Neghab N, Naghshineh E, Khani P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol. 2018;57(6):810\u20133.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"1667_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/jhrs.JHRS_28_17","volume":"10","author":"SR Tandulwadkar","year":"2017","unstructured":"Tandulwadkar SR, Naralkar MV, Surana AD, Selvakarthick M, Kharat AH. Autologous intrauterine Platelet-Rich plasma instillation for suboptimal endometrium in frozen embryo transfer cycles: A pilot study. J Hum Reprod Sci. 2017;10(3):208\u201312.","journal-title":"J Hum Reprod Sci"},{"issue":"6","key":"1667_CR6","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.18632\/aging.203972","volume":"14","author":"Y Cakiroglu","year":"2022","unstructured":"Cakiroglu Y, Yuceturk A, Karaosmanoglu O, Kopuk SY, Korun ZEU, Herlihy N, Scott RT, Tiras B, Seli E. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP). Aging. 2022;14(6):2513\u201323.","journal-title":"Aging"},{"issue":"6","key":"1667_CR7","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3390\/jcm14061952","volume":"14","author":"I Castells","year":"2025","unstructured":"Castells I, Ferrando M, de la Fuente M, Gantxegi M, Quintana F, Mascaros JM, Anitua E, Matorras R. Endometrial infusion with plasma rich in growth factors (PRGF) in IVF cycles: randomized clinical trial in very thin endometrium and observational uncontrolled Follow-Up after the randomized clinical trial. J Clin Med. 2025;14(6):1952.","journal-title":"J Clin Med"},{"key":"1667_CR8","doi-asserted-by":"publisher","first-page":"1374382","DOI":"10.3389\/fendo.2024.1374382","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Li J, Lu W, Gao F, Zhang S, Li J. Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction. Front Endocrinol (Lausanne). 2024;15:1374382.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1667_CR9","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.1038\/s41598-023-39920-x","volume":"13","author":"A Schallmoser","year":"2023","unstructured":"Schallmoser A, Einenkel R, F\u00e4rber C, H\u00fcren V, Emrich N, John J, S\u00e4nger N. Comparison of angiogenic potential in vitrified vs. slow frozen human ovarian tissue. Sci Rep. 2023;13(1):12885.","journal-title":"Sci Rep"},{"issue":"4","key":"1667_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.rbmo.2017.04.007","volume":"35","author":"L Hosseini","year":"2017","unstructured":"Hosseini L, Shirazi A, Naderi MM, Shams-Esfandabadi N, Borjian Boroujeni S, Sarvari A, Sadeghnia S, Behzadi B, Akhondi MM. Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage. Reprod Biomed Online. 2017;35(4):343\u201350.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"1667_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13048-024-01423-2","volume":"17","author":"M Elias","year":"2024","unstructured":"Elias M, Konya M, Kekk Z, Turan C, das Virgens IPA, Toth R, Keszthelyi M, Hegyi P, Varbiro S, Sipos M. Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis. J Ovarian Res. 2024;17(1):104.","journal-title":"J Ovarian Res"},{"key":"1667_CR12","doi-asserted-by":"crossref","unstructured":"Cavallo C, Roffi A, Grigolo B, Mariani E, Pratelli L, Merli G, Kon E, Marcacci M, Filardo G. Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules. Biomed Res Int 2016, 2016:6591717.","DOI":"10.1155\/2016\/6591717"},{"issue":"4","key":"1667_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37796\/2211-8039.1380","volume":"12","author":"NS Rickers","year":"2022","unstructured":"Rickers NS, Sills ES. Is autologous platelet activation the key step in ovarian therapy for fertility recovery and menopause reversal? Biomed (Taipei). 2022;12(4):1\u20138.","journal-title":"Biomed (Taipei)"},{"issue":"4","key":"1667_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12522-016-0236-x","volume":"15","author":"M Shimada","year":"2016","unstructured":"Shimada M, Umehara T, Hoshino Y. Roles of epidermal growth factor (EGF)-like factor in the ovulation process. Reprod Med Biol. 2016;15(4):201\u201316.","journal-title":"Reprod Med Biol"},{"issue":"1","key":"1667_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0028-1108010","volume":"27","author":"M Hsieh","year":"2009","unstructured":"Hsieh M, Zamah AM, Conti M. Epidermal growth factor-like growth factors in the follicular fluid: role in oocyte development and maturation. Semin Reprod Med. 2009;27(1):52\u201361.","journal-title":"Semin Reprod Med"},{"issue":"6","key":"1667_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1530\/rep.1.00978","volume":"131","author":"EE Nilsson","year":"2006","unstructured":"Nilsson EE, Detzel C, Skinner MK. Platelet-derived growth factor modulates the primordial to primary follicle transition. Reproduction. 2006;131(6):1007\u201315.","journal-title":"Reproduction"},{"issue":"2","key":"1667_CR17","doi-asserted-by":"publisher","first-page":"103813","DOI":"10.1016\/j.rbmo.2024.103813","volume":"49","author":"M Serdarogullari","year":"2024","unstructured":"Serdarogullari M, Raad G, Makieva S, Liperis G, Fraire-Zamora JJ, Celik-Ozenci C. Revitalizing female fertility: platelet-rich plasma - hype or hope? Reprod Biomed Online. 2024;49(2):103813.","journal-title":"Reprod Biomed Online"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01667-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01667-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01667-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T11:49:12Z","timestamp":1745495352000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01667-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1667"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01667-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for this in vitro study was approved on November 7, 2022, by the Araba University Hospital Clinical Research Ethics Committee (BTI-01-IV\/22\/CPL).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that E.A. is the Scientific Director of, and M.d.l.F., R.P. and M.H.A. are scientists at BTI-Biotechnology Institute I MAS D, a biomedical company that investigates the fields of regenerative medicine and PRGF-Endoret technology.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}